Oncologix Tech Inc (OCLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 11-2002 | 08-2002 | 05-2002 | 02-2002 | 11-2001 | |
| Sales | 300 | 341 | 297 | 234 | 266 |
| Cost of Goods | 280 | 410 | 280 | 300 | 440 |
| Gross Profit | 10 | -110 | 10 | -60 | -210 |
| Operating Expenses | 1,530 | 1,580 | 1,390 | 1,270 | 1,480 |
| Operating Income | -1,230 | -1,239 | -1,093 | -1,036 | -1,214 |
| Interest Expense | 180 | 530 | 200 | 30 | 0 |
| Other Income | -40 | -211 | 13 | 26 | 14 |
| Pre-tax Income | -1,450 | -1,980 | -1,280 | -1,040 | -1,200 |
| Net Income Continuous | -1,459 | -1,972 | -1,289 | -1,044 | -1,205 |
| Net Income | $-1,459 | $-1,972 | $-1,289 | $-1,044 | $-1,205 |
| EPS Basic Total Ops | -0.32 | -0.64 | -0.32 | -0.28 | -0.40 |
| EPS Basic Continuous Ops | -0.32 | -0.64 | -0.32 | -0.28 | -0.35 |
| EPS Diluted Total Ops | -0.32 | -0.64 | -0.32 | -0.28 | -0.40 |
| EPS Diluted Continuous Ops | -0.32 | -0.64 | -0.32 | -0.28 | -0.35 |
| EBITDA(a) | $-680 | $-689 | $-513 | $-466 | $-644 |